AbbVie Inc. Cost of Revenue 2011-2026 | ABBV
Beta
What is cost of revenue?
Cost of revenue includes the direct costs attributable to producing goods or delivering services sold by the company.
What is AbbVie Inc.'s current cost of revenue?
AbbVie Inc. (ABBV) annual cost of revenue for 2025 was $18.20B, a 7.69% increase from 2024. AbbVie Inc. cost of revenue for the quarter ending March 31, 2026 was $4.22B.
What was AbbVie Inc.'s cost of revenue in 2024?
AbbVie Inc. annual cost of revenue for 2024 was $16.90B, a 17.20% decline from 2023.
What was AbbVie Inc.'s cost of revenue in 2023?
AbbVie Inc. annual cost of revenue for 2023 was $20.41B, a 17.23% increase from 2022.
What is AbbVie Inc.'s 5-year cost of revenue CAGR?
AbbVie Inc. cost of revenue grew at a compound annual growth rate (CAGR) of 3.42% from FY2020 to FY2025, going from $15.39B to $18.20B over 5 years.
Cost of Revenue History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGR+3.4%
FY2020
$15.39B
→
FY2025
$18.20B
111213141516171819202122232425
5 years selected
Cost of Revenue History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $18.20B | +7.7% | 10-K |
| FY2024 | $16.90B | -17.2% | 10-K |
| FY2023 | $20.41B | +17.2% | 10-K |
| FY2022 | $17.41B | -0.2% | 10-K |
| FY2021 | $17.45B | +13.4% | 10-K |
| FY2020 | $15.39B | +106.8% | 10-K |
| FY2019 | $7.44B | -3.6% | 10-K |
| FY2018 | $7.72B | +9.6% | 10-K |
| FY2017 | $7.04B | +20.7% | 10-K |
| FY2016 | $5.83B | +29.6% | 10-K |
| FY2015 | $4.50B | +1.7% | 10-K |
| FY2014 | $4.43B | -3.4% | 10-K |
| FY2013 | $4.58B | +1.6% | 10-K |
| FY2012 | $4.51B | -2.8% | 10-K |
| FY2011 | $4.64B | - | 10-K |
Company: AbbVie Inc.Ticker: ABBVSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →